I-Chow Joe Hsu, MD

Associate Professor, Department of Radiation Oncology, UCSF

Phone: (415) 353-9807 (appts, new), 353-9894 (appts, follow-up)
Box 0226, UCSF
San Francisco, CA 94143-0226

View on UCSF Profiles

Additional Websites

• Physician Referral Directory

Education

University of Florida, Gainesville, FL, BS, 1983-87, Biochemistry
Johns Hopkins School of Med., Baltimore, MD, MD, 1987-91, Medicine
San Bernardino County Med. Ctr., SB, CA, 1991-92, Internship
Columbia-Presbyterian Med. Ctr., NY, NY, 1992-95, Residency

Professional Experience

• 1995-1997
  Attending Physician, Radiation Oncology, California Endocurietherapy Cancer Center, Oakland CA
• 1997-1998
  Clinical Assistant Professor, Department of Radiation Oncology, University of California San Francisco
• 1998-2004
  Assistant Professor of Clinical Radiation Oncology, Department of Radiation Oncology, University of California, San Francisco
• 2004-present
  Associate Professor of Clinical Radiation Oncology, Department of Radiation Oncology, University of California, San Francisco

Honors & Awards

• 1987
  Alpha Epsilon Delta Medical Honor Society
• 1987
  University of Florida, BS, Magna cum Laude
• 1988, 1990
  Dean's Fund for Research, Johns Hopkins School of Medicine
• 1989
  The John Scott McFarland Fund, Johns Hopkins School of Medicine
• 1991
  Accolade for Outstanding Intern, San Bernardino County Hospital

Selected Publications

1. Pinnaduwage DS, Cunha JA, Weinberg V, Krishnamurthy D, Nash M, Hsu IC, Pouliot J. A dosimetric evaluation of using a single treatment plan for multiple treatment fractions within a given applicator insertion in gynecologic brachytherapy. Brachytherapy. 2013 Apr 11.
   View on PubMed
2. Cury FL, Hunt D, Roach M, Shipley W, Gore E, Hsu IC, Krisch RE, Seider MJ, Sandler H, Lawton C. Prostate-specific antigen response after short-term hormone therapy plus external-beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413. Cancer. 2013 Mar 15.
   View on PubMed
3. Chen CP, Weinberg V, Shinohara K, Roach M, Nash M, Gottschalk A, Chang AJ, Hsu IC. Salvage HDR Brachytherapy for Recurrent Prostate Cancer After Previous Definitive Radiation Therapy: 5-Year Outcomes. Int J Radiat Oncol Biol Phys. 2013 Jun 1; 86(2):324-9.
   View on PubMed
4. Pejavar S, Yom SS, Hwang A, Speight J, Gottschalk A, Hsu IC, Roach M, Xia P. Computer-Assisted, Atlas-Based Segmentation for Target Volume Delineation in Whole Pelvic IMRT for Prostate Cancer. Technol Cancer Res Treat. 2013 Jun; 12(3):199-206.
   View on PubMed
5. Siauw T, Cunha A, Berenson D, Atamturk A, Hsu IC, Goldberg K, Pouliot J. NPIP: A skew line needle configuration optimization system for HDR brachytherapy. Med Phys. 2012 Jul; 39(7):4339-46.
   View on PubMed
6. Hsu CC, Hsu H, Pickett B, Crehange G, Hsu IC, Dea R, Weinberg V, Gottschalk AR, Kurhanewicz J, Shinohara K, Roach M. Feasibility of MR Imaging/MR Spectroscopy-Planned Focal Partial Salvage Permanent Prostate Implant (PPI) for Localized Recurrence After Initial PPI for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 1; 85(2):370-7.
   View on PubMed
7. Abdel-Wahab M, Mahmoud O, Merrick G, Hsu IC, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y. ACR Appropriateness Criteria® external-beam radiation therapy treatment planning for clinically localized prostate cancer. J Am Coll Radiol. 2012 Apr; 9(4):233-8.
   View on PubMed
8. Yamada Y, Rogers L, Demanes DJ, Morton G, Prestidge BR, Pouliot J, Cohen GN, Zaider M, Ghilezan M, Hsu IC. American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy. 2012 Jan-Feb; 11(1):20-32.
   View on PubMed
9. Moran BJ, DeRose P, Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Rosenthal SA, Rossi CJ, Yamada Y, Merrick GS. ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer. Am J Clin Oncol. 2011 Dec; 34(6):636-47.
   View on PubMed
10. Shiao SL, Sahgal A, Hu W, Jabbari S, Chuang C, Descovich M, Hsu IC, Gottschalk AR, Roach M, Ma L. Temporal compartmental dosing effects for robotic prostate stereotactic body radiotherapy. Phys Med Biol. 2011 Dec 21; 56(24):7767-75.
    View on PubMed
11. Cunha JA, Pouliot J, Weinberg V, Wang-Chesebro A, Roach M, Hsu IC. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy. Brachytherapy. 2012 Sep-Oct; 11(5):348-53.
    View on PubMed
12. Ciezki JP, Hsu IC, Abdel-Wahab M, Arterbery VE, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G. American College of Radiology Appropriateness Criteria(®)--locally advanced (high-risk) prostate cancer. Clin Oncol (R Coll Radiol). 2012 Feb; 24(1):43-51.
    View on PubMed
13. Siauw T, Cunha A, Atamtürk A, Hsu IC, Pouliot J, Goldberg K. IPIP: A new approach to inverse planning for HDR brachytherapy by directly optimizing dosimetric indices. Med Phys. 2011 Jul; 38(7):4045-51.
    View on PubMed
14. Wootton JH, Prakash P, Hsu IC, Diederich CJ. Implant strategies for endocervical and interstitial ultrasound hyperthermia adjunct to HDR brachytherapy for the treatment of cervical cancer. Phys Med Biol. 2011 Jul 7; 56(13):3967-84.
    View on PubMed
15. American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer. Brachytherapy. 2011 Sep-Oct; 10(5):357-62.
    View on PubMed
16. Reed G, Cunha JA, Noworolski S, Kurhanewicz J, Vigneron D, Hsu IC, Pouliot J. Interactive, multi-modality image registrations for combined MRI/MRSI-planned HDR prostate brachytherapy. J Contemp Brachytherapy. 2011 Mar 31; 3(1):26-31.
    View on PubMed
17. Krishnamurthy D, Weinberg V, Cunha JA, Hsu IC, Pouliot J. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources. Brachytherapy. 2011 Nov-Dec; 10(6):461-5.
    View on PubMed
18. Wootton JH, Hsu IC, Diederich CJ. Endocervical ultrasound applicator for integrated hyperthermia and HDR brachytherapy in the treatment of locally advanced cervical carcinoma. Med Phys. 2011 Feb; 38(2):598-611.
    View on PubMed
19. Jabbari S, Weinberg VK, Kaprealian T, Hsu IC, Ma L, Chuang C, Descovich M, Shiao S, Shinohara K, Roach M, Gottschalk AR. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response. Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82(1):228-34.
    View on PubMed
20. Kaprealian T, Weinberg V, Speight JL, Gottschalk AR, Roach M, Shinohara K, Hsu IC. High-dose-rate brachytherapy boost for prostate cancer: comparison of two different fractionation schemes. Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82(1):222-7.
    View on PubMed

View on UCSF Profiles